|
liver cancer |
18 |
|
hepatocellular carcinoma |
16 |
|
next-generation sequencing |
15 |
|
hcc |
11 |
|
hypoxia |
11 |
|
animals |
10 |
|
molecular biology |
10 |
|
molecular pathology |
10 |
|
signaling |
10 |
|
cell line, tumor |
9 |
|
dna methylation |
9 |
|
gene mutation |
8 |
|
rsk2 |
8 |
|
alpha b-crystallin (cryab) |
7 |
|
alpha-crystallin b chain - physiology |
7 |
|
base sequence |
7 |
|
chromosome 11q |
7 |
|
chromosomes, human, pair 11 |
7 |
|
gene expression regulation, neoplastic |
7 |
|
glycolysis |
7 |
|
irradiation microcell-mediated chromosome transfer |
7 |
|
microcell hybrid |
7 |
|
nasopharyngeal carcinoma |
7 |
|
pfkfb |
7 |
|
animal experiment |
6 |
|
animal model |
6 |
|
cancer stemness plasticity |
6 |
|
carcinoma, hepatocellular - metabolism |
6 |
|
cardiac myosins - metabolism |
6 |
|
eph receptor |
6 |
|
ephrin-a |
6 |
|
jnk |
6 |
|
liver neoplasms - metabolism |
6 |
|
myosin light chains - metabolism |
6 |
|
ros |
6 |
|
srebp |
6 |
|
stc1 |
6 |
|
tumor microenvironment |
6 |
|
tumorigenesis |
6 |
|
antioxidants |
5 |
|
apoptosis |
5 |
|
cancer biomarker |
5 |
|
carcinoma, hepatocellular - metabolism - mortality - secondary |
5 |
|
cell proliferation |
5 |
|
controlled study |
5 |
|
gene knockdown techniques |
5 |
|
glutathione |
5 |
|
humans |
5 |
|
immunotherapy |
5 |
|
liver neoplasms - metabolism - mortality - pathology |
5 |
|
metabolism |
5 |
|
micrornas - metabolism |
5 |
|
n-acetylcysteine |
5 |
|
non-coding rna |
5 |
|
nrf2 |
5 |
|
reactive oxygen species |
5 |
|
rho-associated kinases - analysis - metabolism |
5 |
|
sorafenib |
5 |
|
tmbim1 |
5 |
|
tumor progression |
5 |
|
actins - metabolism |
4 |
|
amino acid sequence |
4 |
|
animal |
4 |
|
bagg albino mouse |
4 |
|
breast neoplasms - pathology |
4 |
|
c57bl mouse |
4 |
|
cancer |
4 |
|
carcinoma, hepatocellular - enzymology - pathology |
4 |
|
carcinoma, hepatocellular - genetics |
4 |
|
cell hypoxia |
4 |
|
cell movement |
4 |
|
cell survival |
4 |
|
chromatin assembly and disassembly |
4 |
|
clustered regularly interspaced short palindromic repeat |
4 |
|
collagen - metabolism |
4 |
|
crispr library screening |
4 |
|
drug-resistance |
4 |
|
extracellular matrix |
4 |
|
female |
4 |
|
gene silencing |
4 |
|
genes, tumor suppressor - physiology |
4 |
|
genetic transfection |
4 |
|
glycoproteins - genetics |
4 |
|
golgi apparatus - physiology |
4 |
|
hypoxia-inducible factor 1 - genetics - physiology |
4 |
|
immune regulation |
4 |
|
inhibitor |
4 |
|
liver - pathology |
4 |
|
liver neoplasms - enzymology - pathology |
4 |
|
liver neoplasms - genetics |
4 |
|
lung metastasis |
4 |
|
metastasis |
4 |
|
mice |
4 |
|
mice, inbred balb c |
4 |
|
mice, nude |
4 |
|
mitochondria |
4 |
|
mouse model |
4 |
|
myosin-light-chain phosphatase - metabolism |
4 |
|
neoplasm invasiveness |
4 |
|
neoplasm metastasis |
4 |
|
phosphorylation |
4 |
|
pim kinase |
4 |
|
pseudopodia - metabolism |
4 |
|
rho gtpase |
4 |
|
rho-associated kinase |
4 |
|
rho-associated kinases - metabolism |
4 |
|
stress fibers - metabolism |
4 |
|
tace |
4 |
|
therapeutics |
4 |
|
cancer metabolism |
3 |
|
cancer metastasis |
3 |
|
cancer therapy |
3 |
|
carcinoma, hepatocellular - genetics - mortality - pathology - secondary |
3 |
|
cytokeratin 19 |
3 |
|
cytoskeletal reorganization |
3 |
|
demethylation |
3 |
|
epigenetics |
3 |
|
fact complex |
3 |
|
g9a |
3 |
|
gastrointestinal cancer |
3 |
|
gene amplification |
3 |
|
hbv-associated multistep |
3 |
|
hepatocarcinogenesis |
3 |
|
histone h3 |
3 |
|
histone modifications |
3 |
|
hottip |
3 |
|
hydrodynamic tail vein injection |
3 |
|
immunogenic cell death |
3 |
|
lipid peroxidation |
3 |
|
liver neoplasms - genetics - mortality - pathology |
3 |
|
lncrna |
3 |
|
microrna |
3 |
|
microrna expression |
3 |
|
micrornas - genetics - metabolism |
3 |
|
mir-1 |
3 |
|
mir-125b |
3 |
|
mir-200 family |
3 |
|
mirna |
3 |
|
molecular pathogenesis |
3 |
|
pim1 |
3 |
|
ppp |
3 |
|
preclinical models |
3 |
|
rarres3 |
3 |
|
regulated cell death |
3 |
|
rho |
3 |
|
rho gtp-binding proteins - metabolism |
3 |
|
rho/rock signaling pathway |
3 |
|
rock |
3 |
|
ssrp1 |
3 |
|
supt16h |
3 |
|
tkt |
3 |
|
vascular neoplasms - genetics - mortality - secondary |
3 |
|
cancer cells. |
2 |
|
cell transformation, neoplastic - genetics |
2 |
|
disease progression |
2 |
|
gene expression profiling |
2 |
|
liver - cancer - molecular aspects. |
2 |
|
liver diseases - genetics |
2 |
|
medical sciences |
2 |
|
metastasis. |
2 |
|
protein kinases. |
2 |
|
serine proteinases. |
2 |
|
tumor suppressor proteins. |
2 |
|
adoptive t cell therapy |
1 |
|
bmdc (bone marrow-derived cell) |
1 |
|
bone marrow cells - drug effects - metabolism - pathology |
1 |
|
breast neoplasms - genetics - metabolism - pathology |
1 |
|
cardiac glycosides |
1 |
|
crispr/cas9 library screening |
1 |
|
dietary intervention |
1 |
|
drug resistance |
1 |
|
glutamine depletion |
1 |
|
hepatocellular carcinoma (hcc) |
1 |
|
hif |
1 |
|
hif-1 |
1 |
|
hif1α |
1 |
|
hypoxia-inducible factor (hif) |
1 |
|
hypoxia-inducible factor 1 - antagonists and inhibitors - metabolism |
1 |
|
immunology |
1 |
|
individualized therapy |
1 |
|
luciferase reporter assay |
1 |
|
lung neoplasms - genetics - metabolism - secondary |
1 |
|
mdsc (myeloid-derived suppressor cell) |
1 |
|
metabolic reprogramming |
1 |
|
muscle satellite cell |
1 |
|
pmn (premetastatic niche) |
1 |
|
pyruvate metabolism |
1 |
|
qpcr |
1 |
|
skeletal muscle regeneration |
1 |
|
tam (tumor-associated macrophage) |
1 |
|
targeted therapy |
1 |
|
tkis |
1 |
|
treg (regulatory t cell) |
1 |
|
triple-negative breast cancer |
1 |
|
western blotting |
1 |
|
yy1 |
1 |
